BRKR Profile
Bruker Corporation is a leading developer, manufacturer, and global distributor of scientific instruments, analytical tools, and diagnostic solutions with operations spanning across the United States and international markets. Organized into three primary segments Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies the company offers an extensive range of products and services tailored for various scientific disciplines. Its offerings include life science tools, mass spectrometry systems, and advanced molecular diagnostics platforms such as the MALDI Biotyper for rapid pathogen identification and fluorescence-based PCR technology.
Bruker's portfolio also encompasses analytical instruments for electron microscopy, X-ray analysis, atomic force microscopy, and non-contact nanometer resolution imaging. The company is at the forefront of COVID-19 diagnostics with its SARS-CoV-2 testing solutions, underscoring its commitment to healthcare advancements and public health initiatives. Moreover, Bruker provides innovative solutions in portable analytical systems, X-ray fluorescence spectrometry, and superconducting materials used in various high-tech applications.
Founded in 1991 and headquartered in Billerica, Massachusetts, Bruker Corporation collaborates extensively with industry partners and researchers to drive innovation in drug discovery, biomarker identification, and materials science. With a strong emphasis on technological excellence and customer-centric solutions, Bruker continues to expand its global footprint and enhance its capabilities in supporting scientific research and diagnostic advancements worldwide.
|